Mayank Mamtani
Stock Analyst at B. Riley Securities
(4.14)
# 1,593
Out of 4,994 analysts
1079
Total ratings
38.9%
Success rate
6.7%
Average return
Main Sectors:
Stocks Rated by Mayank Mamtani
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUE Cue Biopharma | Initiated Coverage: Buy | $83 | $30.90 | +168.61% | 1 | Sep 18, 2026 | |
| XGN Exagen | Reiterated: Buy | $12 | $8.74 | +37.30% | 1 | Sep 11, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | $26 → $30 | $14.21 | +111.12% | 2 | Sep 4, 2026 | |
| AAPG Ascentage Pharma Group International | Reiterated: Buy | $45 | $15.87 | +183.55% | 2 | Sep 2, 2026 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Initiated Coverage: Buy | $15.45 | $2.67 | +478.49% | 1 | Aug 26, 2026 | |
| DNLI Denali Therapeutics | Reiterated: Buy | $30 → $35 | $21.60 | +62.04% | 26 | Aug 25, 2026 | |
| MGNX MacroGenics | Reiterated: Buy | $9 → $11 | $4.12 | +166.99% | 10 | Aug 17, 2026 | |
| UNCY Unicycive Therapeutics | Reiterated: Buy | $22 → $20 | $4.96 | +303.23% | 3 | Aug 13, 2026 | |
| HROW Harrow | Reiterated: Buy | $60 | $34.45 | +74.17% | 30 | Aug 10, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $40 → $44 | $27.57 | +59.62% | 5 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $6.10 | +129.51% | 4 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 → $31 | $15.24 | +103.41% | 23 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 → $146 | $67.59 | +116.01% | 24 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $14 | $8.70 | +60.92% | 82 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $170 | $118.14 | +43.90% | 1 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $117 → $155 | $122.06 | +26.99% | 4 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $1.87 | +1,343.85% | 1 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $30.32 | +48.42% | 6 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $10.83 | +66.20% | 118 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.91 | +229.67% | 16 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $17 | $17.03 | -0.18% | 3 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $7.25 | +65.52% | 2 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $1.04 | +284.62% | 17 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $14.38 | +52.99% | 25 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $150 | $60.97 | +146.02% | 9 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $7.88 | +255.56% | 3 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $33 | $18.19 | +81.47% | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $55 | $58.11 | n/a | 65 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.8074 | n/a | 1 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $12.11 | n/a | 5 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $18 | $3.41 | n/a | 71 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $40.85 | n/a | 34 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $71.86 | n/a | 78 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $422 → $460 | $518.83 | n/a | 57 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 → $2 | $0.4801 | n/a | 35 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 → $2 | $0.9813 | n/a | 23 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $57.09 | n/a | 1 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.45 | n/a | 30 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.531 | n/a | 15 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8899 | n/a | 16 | Jul 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $140 | $5.35 | n/a | 4 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $3.43 | n/a | 25 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.63 | n/a | 16 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.03 | n/a | 23 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.001 | n/a | 10 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.95 | n/a | 8 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.16 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 14 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.90 | n/a | 14 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.24 | n/a | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $120 | $16.73 | n/a | 7 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $10 | $10.34 | n/a | 14 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $38.07 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.01 | n/a | 26 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.10 | n/a | 19 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0005 | n/a | 7 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.14 | n/a | 7 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.16 | n/a | 10 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.42 | n/a | 4 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.13 | n/a | 1 | May 12, 2020 |
Cue Biopharma
Sep 18, 2026
Initiated Coverage: Buy
Price Target: $83
Current: $30.90
Upside: +168.61%
Exagen
Sep 11, 2026
Reiterated: Buy
Price Target: $12
Current: $8.74
Upside: +37.30%
Climb Bio
Sep 4, 2026
Reiterated: Buy
Price Target: $26 → $30
Current: $14.21
Upside: +111.12%
Ascentage Pharma Group International
Sep 2, 2026
Reiterated: Buy
Price Target: $45
Current: $15.87
Upside: +183.55%
Cardiol Therapeutics Inc.
Aug 26, 2026
Initiated Coverage: Buy
Price Target: $15.45
Current: $2.67
Upside: +478.49%
Denali Therapeutics
Aug 25, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $21.60
Upside: +62.04%
MacroGenics
Aug 17, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $4.12
Upside: +166.99%
Unicycive Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $22 → $20
Current: $4.96
Upside: +303.23%
Harrow
Aug 10, 2026
Reiterated: Buy
Price Target: $60
Current: $34.45
Upside: +74.17%
Zymeworks
Aug 10, 2026
Reiterated: Buy
Price Target: $40 → $44
Current: $27.57
Upside: +59.62%
Aug 7, 2026
Reiterated: Buy
Price Target: $12 → $14
Current: $6.10
Upside: +129.51%
Aug 7, 2026
Initiated Coverage: Buy
Price Target: $16 → $31
Current: $15.24
Upside: +103.41%
Jul 31, 2026
Reiterated: Buy
Price Target: $108 → $146
Current: $67.59
Upside: +116.01%
Jul 30, 2026
Reiterated: Buy
Price Target: $8 → $14
Current: $8.70
Upside: +60.92%
Jul 15, 2026
Initiated Coverage: Buy
Price Target: $170
Current: $118.14
Upside: +43.90%
Jun 29, 2026
Rated: Buy
Price Target: $117 → $155
Current: $122.06
Upside: +26.99%
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $1.87
Upside: +1,343.85%
May 29, 2026
Reiterated: Buy
Price Target: $45
Current: $30.32
Upside: +48.42%
Apr 9, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $10.83
Upside: +66.20%
Apr 7, 2026
Reiterated: Buy
Price Target: $3
Current: $0.91
Upside: +229.67%
Apr 7, 2026
Reiterated: Hold
Price Target: $14 → $17
Current: $17.03
Upside: -0.18%
Mar 26, 2026
Rated: Buy
Price Target: $12
Current: $7.25
Upside: +65.52%
Mar 25, 2026
Reiterated: Buy
Price Target: $3 → $4
Current: $1.04
Upside: +284.62%
Mar 18, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $14.38
Upside: +52.99%
Feb 23, 2026
Reiterated: Buy
Price Target: $105 → $150
Current: $60.97
Upside: +146.02%
Oct 6, 2025
Reiterated: Buy
Price Target: $28
Current: $7.88
Upside: +255.56%
Oct 3, 2025
Reiterated: Buy
Price Target: $29 → $33
Current: $18.19
Upside: +81.47%
Sep 17, 2025
Reiterated: Buy
Price Target: $53 → $55
Current: $58.11
Upside: n/a
Aug 26, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $0.8074
Upside: n/a
Aug 19, 2025
Reiterated: Buy
Price Target: $43
Current: $12.11
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $20 → $18
Current: $3.41
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: $85
Current: $40.85
Upside: n/a
May 14, 2025
Reiterated: Buy
Price Target: $38
Current: $71.86
Upside: n/a
May 2, 2025
Reiterated: Buy
Price Target: $422 → $460
Current: $518.83
Upside: n/a
Mar 27, 2025
Reiterated: Buy
Price Target: $2.5 → $2
Current: $0.4801
Upside: n/a
Feb 6, 2025
Reiterated: Buy
Price Target: $1.5 → $2
Current: $0.9813
Upside: n/a
Jan 9, 2025
Initiated Coverage: Buy
Price Target: $21
Current: $57.09
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $2.45
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $0.531
Upside: n/a
Jul 5, 2024
Rated: Hold
Price Target: n/a
Current: $0.8899
Upside: n/a
Jun 14, 2024
Reiterated: Buy
Price Target: $4 → $140
Current: $5.35
Upside: n/a
May 17, 2023
Reiterated: Buy
Price Target: $3 → $4
Current: $3.43
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $1.63
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $1.03
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.001
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.95
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $2.16
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 15, 2022
Reiterated: Buy
Price Target: $6
Current: $2.90
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $1.24
Upside: n/a
Mar 31, 2022
Reiterated: Buy
Price Target: $3 → $120
Current: $16.73
Upside: n/a
Mar 23, 2022
Reiterated: Buy
Price Target: $17 → $10
Current: $10.34
Upside: n/a
Nov 12, 2021
Reiterated: Buy
Price Target: $67
Current: $38.07
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $5.01
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $10.10
Upside: n/a
Jul 2, 2021
Rated: Hold
Price Target: n/a
Current: $0.0005
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $4.14
Upside: n/a
Oct 6, 2020
Rated: Hold
Price Target: n/a
Current: $2.16
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $10.42
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: n/a
Current: $16.13
Upside: n/a